Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20180938 | 0.84 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL19443251 | 0.84 | TDP1 (0.36) | TSHRTDP1 | |
| SCHEMBL2202085 | 0.81 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL16645136 | 0.80 | — | — | |
| SCHEMBL25765713 | 0.80 | — | — | |
| SCHEMBL25762374 | 0.80 | — | — | |
| SCHEMBL25626099 | 0.80 | — | — | |
| SCHEMBL8776851 | 0.79 | — | — | |
| SCHEMBL19750447 | 0.78 | — | — | |
| SCHEMBL17735463 | 0.77 | OR51E2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230097382-A1 | DEVICES AND METHODS FOR QUANTIFYING FATTY ACIDS | 1000519753 ONTARIO INC. (CA) | 2023-03-30 | — | — | US | disclosed |
| EP-2228378-B1 | MONOSEBACATE OF PYRAZOLE DERIVATIVE | KISSEI PHARMACEUTICAL (JP) | 2015-09-09 | — | — | EP | disclosed |
| US-8399418-B2 | Monosebacate of pyrazole derivative | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20100279962-A1 | MONOSEBACATE OF PYRAZOLE DERIVATIVE | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2228378-A1 | MONOSEBACATE OF PYRAZOLE DERIVATIVE | Kissei Pharmaceutical Co., Ltd. (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-20070020479-A1 | Luminescent-polymer composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279962-A1 | MONOSEBACATE OF PYRAZOLE DERIVATIVE | GALE, MGAT3, MGAM | TSHR 3577/4885TDP1 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.